C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2011
12/27/2011	US8084437 Methods for treating hypercholesterolemia
12/27/2011	US8084436 Modulation of SGLT2 expression
12/27/2011	US8084433 Antisense antiviral compound and method for treating ssRNA viral infection
12/27/2011	US8084432 Compositions and methods for treatment of pouchitis
12/27/2011	US8084425 Dopaminergic neuronal survival-promoting factors and uses thereof
12/27/2011	US8084422 Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity
12/27/2011	US8084418 toxin complex (TC) proteins, obtained from Xenorhabdus, Photorhabdus, and Paenibacillus; toxicity of an insectidal protein is enhanced by a potentiator protein of a different organism; reduces the number of genes (and transformation events) needed to be coexpressed by transgenic plants for insect control
12/27/2011	US8084413 Urocortin-III and uses thereof
12/27/2011	US8084256 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084253 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084252 Recombinant cell clones having increased stability and methods of making and using the same
12/27/2011	US8084251 Recombinant cell clones having increased stability and methods of making and using the same
12/27/2011	US8084250 Defensin-antigen fusion proteins
12/27/2011	US8084249 Vector
12/27/2011	US8084248 Reverse genetic system for rift valley fever virus and uses thereof
12/27/2011	US8084245 Apparatus and method for polymer synthesis using arrays
12/27/2011	US8084241 Subtilases
12/27/2011	US8084238 Process for producing glycolic acid from formaldehyde and hydrogen cyanide
12/27/2011	US8084234 Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF
12/27/2011	US8084233 Nucleic acids encoding anti-IL-12 antibody
12/27/2011	US8084232 Polynucleotides encoding Papio cynocephalus toll-like receptor 3
12/27/2011	US8084231 Soluble IL-17RA/RC fusion proteins and related methods
12/27/2011	US8084229 GDEP enhancer element and use thereof to confer retinal specific gene expression
12/27/2011	US8084228 Nogo-B receptor antagonists
12/27/2011	US8084213 Selection
12/27/2011	US8084200 Compositions and methods for the diagnosis and treatment of tumor
12/27/2011	US8084042 Polypeptide comprising a soluble Mycobacterium tuberculosis antigen; vaccines
12/27/2011	US8084037 Recombinant parainfluenza virus expression systems and vaccines
12/27/2011	US8084033 Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment
12/27/2011	US8084029 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
12/27/2011	US8084028 Antibodies to VLA-1
12/27/2011	US8084021 Recombinant human albumin-interleukin-11 fusion protein with long-lasting biological effects
12/27/2011	US8084017 In situ genetic engineering; generating image
12/27/2011	US8084015 Immunostimulatory complex of a cationic peptide immunogen and anionic CpG single-stranded DNA oligonucleotide
12/27/2011	US8083917 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
12/22/2011	WO2011160063A2 Methods and materials for assessing loss of heterozygosity
12/22/2011	WO2011160057A1 Inhibition of snl6 expression for biofuel production
12/22/2011	WO2011160050A2 Systems to reduce recalcitrance of cellulosic biomass and increase yields of fermentable sugars
12/22/2011	WO2011160026A2 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
12/22/2011	WO2011159938A2 High affinity human antibodies to human cytomegalovirus (cmv) gb protein
12/22/2011	WO2011159928A2 Anti-dr4 agonist antibodies
12/22/2011	WO2011159924A2 Compositions and methods for identifying and modifying carbonaceous compositions
12/22/2011	WO2011159853A1 Recombinant host cells comprising phosphoketolases
12/22/2011	WO2011159835A1 Antibodies to endoplasmin and their use
12/22/2011	WO2011159797A2 A compendium of ready-built stem cell models for interrogation of biological response
12/22/2011	WO2011159762A1 Methods of limiting microvascular damage following acute myocardial ischemia
12/22/2011	WO2011159758A2 Long lasting drug formulations
12/22/2011	WO2011159745A1 Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
12/22/2011	WO2011159713A2 Compositions and methods for gene expression and chromatin profiling of individual cell types within a tissue
12/22/2011	WO2011159692A1 Improved methods for producing induced pluripotent stem cells
12/22/2011	WO2011159369A1 Nuclease activity of tal effector and foki fusion protein
12/22/2011	WO2011159328A1 Methods of treatment using tlr7 and/or tlr9 inhibitors
12/22/2011	WO2011159157A1 Novel intergenic elements for enhancing gene expression
12/22/2011	WO2011159092A2 Novel soil microorganism, novel oxidoreductase separated from the soil microorganism, gene encoding the oxidoreductase, and method for producing aglycones using the microorganism, the oxidoreductase and the gene
12/22/2011	WO2011159004A1 Snp for predicting the sensitivity to anticancer targeted therapeutic formulation
12/22/2011	WO2011159000A1 Human monoclonal antibody that binds specifically with oxidized low-density lipoprotein and carbamylated low-density lipoprotein, and antigen-binding fragment thereof
12/22/2011	WO2011158987A1 Dna chip for genotyping of human papilloma virus, kit having same, and method for genotyping
12/22/2011	WO2011158975A1 Production process for amino acids of the aspartate family using microorganisms
12/22/2011	WO2011158973A1 Novel antifibrin antibody
12/22/2011	WO2011158967A1 Method for efficiently establishing induced pluripotent stem cell
12/22/2011	WO2011158895A1 Method for constructing recombinant bacterium for producing non-native protein, and utilization of same
12/22/2011	WO2011158864A1 Retinol-modified collagen, method for producing same, and external composition for skin containing same
12/22/2011	WO2011158863A1 Novel substrate peptide of protein kinase
12/22/2011	WO2011158852A1 Process for production of induced pluripotent stem cell
12/22/2011	WO2011158847A1 Kit for detection of gene targeted by microrna, and method for detection of gene targeted by microrna
12/22/2011	WO2011158845A1 Process for production of induced pluripotent stem cell, and induced pluripotent stem cell produced by the process
12/22/2011	WO2011158815A1 Method for simultaneous achievement of bacteriolysis of acid-fast bacterium and separation of nucleic acid from the bacterium
12/22/2011	WO2011158784A1 Method for large-scale parallel nucleic acid analysis
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011158623A1 Production method for large region duplication in aspergillus chromosome
12/22/2011	WO2011158009A1 Animal models and therapeutic molecules
12/22/2011	WO2011157976A1 Control of plant seed shattering
12/22/2011	WO2011157877A1 Heat-resistant endoxylanase obtained by mutagenesis and the use thereof in the bioethanol production process
12/22/2011	WO2011157806A1 Modified alpha-gliadins
12/22/2011	WO2011157791A1 Overproduction of jasmonic acid in transgenic plants
12/22/2011	WO2011157761A1 Increased protein expression through increased membrane formation
12/22/2011	WO2011157717A1 Novel polypeptides having nad(p)h oxidase activity and the use thereof
12/22/2011	WO2011157683A1 Extraction of nucleic acids from wax-embedded samples
12/22/2011	WO2011157496A1 Cell and process for the preparation of resveratrol
12/22/2011	WO2011157448A1 Methods of generating and screening for lytic chimeric polypeptides
12/22/2011	WO2011157447A2 Modified parvovirus having enhanced anti-tumour efficacy
12/22/2011	WO2011157438A1 Dna polymerases with increasesed 3'-mismatch discrimination
12/22/2011	WO2011157436A1 Dna polymerases with increased 3'-mismatch discrimination
12/22/2011	WO2011157433A1 Dna polymerases with increased 3'-mismatch discrimination
12/22/2011	WO2011157294A1 Compositions for use in treating or preventing cancer, breast cancer, lung cancer, ovarian cancer, metastasis, heart failure, cardiac remodelling, dilated cardiomyopathy, autoimmune diseases, or diseases or disorders related thereto
12/22/2011	WO2011157231A1 Novel endo-xylanase, encoding gene and use thereof
12/22/2011	WO2011156970A1 Uses of mtea in diagnosis and treatment of malignant tumor
12/22/2011	WO2011156831A1 Formation of nucleic acid within a polymeric capsule
12/22/2011	WO2011140644A8 Polyacetal or polyketal and ether polymers
12/22/2011	WO2011133878A3 Compositions and methods for selectively producing sirna
12/22/2011	WO2011132836A3 Ethanol-resistant yeast gene, and use thereof
12/22/2011	WO2011132835A3 Ethanol-, heat- or furfural- resistant yeast strain, and gene thereof
12/22/2011	WO2011112902A3 Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (viper)
12/22/2011	WO2011112891A3 Plant defensive peptides
12/22/2011	WO2011110955A3 Methods of testing for intracellular pathogens
12/22/2011	WO2011109618A3 Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding oxidoreductase motif polypeptides
12/22/2011	WO2011103011A3 Gene fusion targeted therapy
12/22/2011	WO2011100330A3 Compositions and methods for preventing or treating a human parvovirus infection
12/22/2011	WO2011100057A3 Methods and compositions for universal detection of nucleic acids
12/22/2011	WO2011097447A3 Production of recombinant virus

1 ... 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 ... 4023